Shares in Boston Scientific (NYSE:BSX) have risen slightly this morning after the medical device maker posted fourth quarter and full year 2018 earnings that topped consensus on Wall Street.
The Marlborough, Mass.-based company posted profits of $386 million, or 27¢ per share, on sales of approximately $2.6 billion for the three months ended December 31, seeing a swing from the red on the bottom line while sales grew 6.4% compared with the same period during the previous year.
